跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CELSENTRI maraviroc 300 mg tablets blister packs - TGA Drug Approval Details
Approvals
/
TGA
/
CELSENTRI maraviroc 300 mg tablets blister packs
Approved
STANDARD
CELSENTRI maraviroc 300 mg tablets blister packs
ViiV Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
8a00087299ef0229
Company
ViiV Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
8a00087299ef0229
Product Name
CELSENTRI maraviroc 300 mg tablets blister packs
Artg Id
137331
Artg Name
CELSENTRI maraviroc 300 mg tablets blister packs
Sponsor
ViiV Healthcare Pty Ltd
Company Detail Path
/organization/viiv-healthcare-pty-ltd
Artg Date
2008-02-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/cb4f71a42eec2637b05c574957f59b1d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/d39d07b37f8da55177951878d27b55ee.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
8a00087299ef0229
Type
Standard
Back to TGA Approvals